As of January 23, 2025, Soligenix (SNGX) has a market cap of $6.173 million USD. According to our data, Soligenix is ranked No.8998 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $6.17 M |
-8.89%
|
Dec 31, 2024 | $6.78 M |
-77.80%
|
Dec 29, 2023 | $30.52 M |
-88.74%
|
Dec 30, 2022 | $0.27 B |
-31.82%
|
Dec 31, 2021 | $0.40 B |
-48.44%
|
Dec 31, 2020 | $0.77 B |
-11.72%
|
Dec 31, 2019 | $0.87 B |
68.60%
|
Dec 31, 2018 | $0.52 B |
-61.26%
|
Dec 29, 2017 | $1.34 B |
-1.33%
|
Dec 30, 2016 | $1.36 B |
-80.09%
|
Dec 31, 2015 | $6.81 B |
15.31%
|
Dec 31, 2014 | $5.90 B |
-45.56%
|
Dec 31, 2013 | $10.84 B |
200.00%
|
Dec 31, 2012 | $3.61 B |
0.00%
|
Dec 30, 2011 | $3.61 B |
-84.21%
|
Dec 31, 2010 | $22.89 B |
-24.00%
|
Dec 31, 2009 | $30.11 B |
316.67%
|
Dec 31, 2008 | $7.23 B |
-64.71%
|
Dec 31, 2007 | $20.48 B |
-29.17%
|
Dec 29, 2006 | $28.91 B |
-11.11%
|
Dec 30, 2005 | $32.52 B |
-57.81%
|
Dec 31, 2004 | $77.09 B |
-17.95%
|
Dec 31, 2003 | $93.96 B |
65.96%
|
Dec 31, 2002 | $56.61 B |
-54.37%
|
Dec 31, 2001 | $124.07 B |
3.00%
|
Dec 29, 2000 | $120.46 B |
-63.64%
|
Dec 31, 1999 | $331.25 B |
33.33%
|
Dec 31, 1998 | $248.44 B |
-62.50%
|
Dec 31, 1997 | $662.51 B |
-58.10%
|
Dec 31, 1996 | $1.581 T |
1,300.00%
|
Dec 29, 1995 | $112.93 B |
-50.00%
|
Dec 30, 1994 | $225.86 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Calithera Biosciences
CALA
|
$0.00 M |
0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Agenus
AGEN
|
$86.42 M |
0.000 M
|
USA
|
Veeva Systems
VEEV
|
$37.19 B |
0.002 M
|
USA
|
Market Cap | = | SNGX Stock Price | * | SNGX Shares Outstanding |
= | $2.46 | * | 2.51 M | |
= | $6.17 M |